The metabolism of Nicotine can be decreased when combined with Valsartan. The metabolism of Amlodipine can be increased when combined with Lumacaftor. The risk or severity of adverse effects can be increased when Valsartan is combined with Benazepril. The risk or severity of adverse effects can be increased when Cabergoline is combined with Amlodipine. Udenafil may increase the antihypertensive activities of Valsartan. The metabolism of Zalcitabine can be decreased when combined with Valsartan. Valsartan may increase the hypotensive activities of Vincamine. Amlodipine may increase the hypotensive activities of BQ-123. The risk or severity of adverse effects can be increased when Valsartan is combined with Acebutolol. The metabolism of Caffeine can be decreased when combined with Valsartan. The risk or severity of adverse effects can be increased when Valsartan is combined with Droxicam. The serum concentration of Amlodipine can be increased when it is combined with Aprepitant. The risk or severity of adverse effects can be increased when Valsartan is combined with Nifedipine. The serum concentration of Simvastatin can be increased when it is combined with Amlodipine. The therapeutic efficacy of Amlodipine can be decreased when used in combination with Calcium lactate. The risk or severity of adverse effects can be increased when Levobupivacaine is combined with Valsartan. The metabolism of Valsartan can be decreased when combined with Capecitabine. The risk or severity of adverse effects can be increased when Amlodipine is combined with Nisoldipine. The risk or severity of adverse effects can be increased when Amlodipine is combined with Apraclonidine. Valsartan may increase the hyperkalemic activities of Cyclosporine. The metabolism of Valsartan can be decreased when combined with Sulfisoxazole. The serum concentration of Amlodipine can be increased when it is combined with Fosaprepitant. The risk or severity of adverse effects can be increased when Tavaborole is combined with Amlodipine. Benmoxin may increase the hypotensive activities of Amlodipine. The risk or severity of adverse effects can be increased when Clofarabine is combined with Valsartan. The risk or severity of adverse effects can be increased when Amlodipine is combined with Propranolol. The risk or severity of adverse effects can be increased when Reserpine is combined with Amlodipine. The risk or severity of adverse effects can be increased when Valsartan is combined with Bumetanide. The risk or severity of adverse effects can be increased when Valsartan is combined with Ketorolac. The risk or severity of adverse effects can be increased when Ropinirole is combined with Amlodipine. The risk or severity of adverse effects can be increased when Valsartan is combined with Indoprofen. The risk or severity of adverse effects can be increased when Natamycin is combined with Amlodipine. Nadroparin may increase the hyperkalemic activities of Valsartan. Mirodenafil may increase the antihypertensive activities of Valsartan. Methohexital may increase the hypotensive activities of Amlodipine. The risk or severity of adverse effects can be increased when Caspofungin is combined with Amlodipine. The metabolism of Methadone can be decreased when combined with Valsartan. The metabolism of Clopidogrel can be decreased when combined with Valsartan. The risk or severity of adverse effects can be increased when Terconazole is combined with Amlodipine. The serum concentration of Amlodipine can be increased when it is combined with Mifepristone. Thiopental may increase the hypotensive activities of Valsartan. The metabolism of Promazine can be decreased when combined with Valsartan. Amphetamine may increase the hypotensive activities of Amlodipine. The risk or severity of adverse effects can be increased when Amlodipine is combined with Hydralazine. Valsartan may increase the hypotensive activities of Tolazoline. The serum concentration of Doxorubicin can be increased when it is combined with Amlodipine. The risk or severity of adverse effects can be increased when Valsartan is combined with E-6201. Amlodipine may increase the neuromuscular blocking activities of Atracurium besylate. The risk or severity of adverse effects can be increased when Amlodipine is combined with Losartan. The risk or severity of adverse effects can be increased when Amlodipine is combined with Terazosin. Amlodipine may increase the hypotensive activities of Rescinnamine. Valsartan may increase the hypotensive activities of Hexamethonium. The serum concentration of Amlodipine can be increased when it is combined with Luliconazole. Valsartan may increase the hypotensive activities of Bimatoprost. The metabolism of Atazanavir can be decreased when combined with Valsartan. Tolvaptan may increase the hyperkalemic activities of Valsartan. The metabolism of Valsartan can be increased when combined with Carbamazepine. The risk or severity of adverse effects can be increased when Amlodipine is combined with Verapamil. The risk or severity of adverse effects can be increased when Amlodipine is combined with Papaverine. Valsartan may increase the hypotensive activities of Phenoxybenzamine. Valsartan may increase the hypotensive activities of Terlipressin. The metabolism of Valsartan can be decreased when combined with Clotrimazole. The risk or severity of adverse effects can be increased when Levobupivacaine is combined with Amlodipine. Amlodipine may increase the hypotensive activities of Spirapril. The metabolism of Etoricoxib can be decreased when combined with Valsartan. The serum concentration of Amlodipine can be decreased when it is combined with Tocilizumab. Amlodipine may increase the hypotensive activities of Lercanidipine. The risk or severity of adverse effects can be increased when Conivaptan is combined with Valsartan. The risk or severity of adverse effects can be increased when Amlodipine is combined with Nadolol. The risk or severity of adverse effects can be increased when Valsartan is combined with Candesartan cilexetil. The risk or severity of adverse effects can be increased when Butenafine is combined with Amlodipine. The metabolism of Amlodipine can be decreased when combined with Telaprevir. The serum concentration of Ibrutinib can be increased when it is combined with Amlodipine. The risk or severity of adverse effects can be increased when Valsartan is combined with Bucillamine. The risk or severity of adverse effects can be increased when Sevoflurane is combined with Valsartan. The risk or severity of adverse effects can be increased when Amlodipine is combined with Irbesartan. Octamoxin may increase the hypotensive activities of Amlodipine. The risk or severity of adverse effects can be increased when Valsartan is combined with Methyclothiazide. Bucindolol may increase the hypotensive activities of Amlodipine. The metabolism of Acenocoumarol can be decreased when combined with Valsartan. The metabolism of Eszopiclone can be decreased when combined with Valsartan. The metabolism of Amlodipine can be decreased when combined with Idelalisib. Amlodipine may increase the hypotensive activities of Enalaprilat. The risk or severity of adverse effects can be increased when Methyclothiazide is combined with Amlodipine. The metabolism of Flurbiprofen can be decreased when combined with Valsartan. The metabolism of Amlodipine can be increased when combined with Rifapentine. The risk or severity of adverse effects can be increased when Amlodipine is combined with Azilsartan medoxomil. The risk or severity of adverse effects can be increased when Valsartan is combined with Azilsartan medoxomil. The risk or severity of adverse effects can be increased when Chlorpromazine is combined with Valsartan. The metabolism of Valsartan can be decreased when combined with Fluconazole. The risk or severity of adverse effects can be increased when Sulconazole is combined with Amlodipine. The serum concentration of Naloxegol can be increased when it is combined with Amlodipine. The metabolism of Indomethacin can be decreased when combined with Valsartan. The metabolism of Bexarotene can be decreased when combined with Valsartan. Dihydralazine may increase the hypotensive activities of Amlodipine. Trans-2-Phenylcyclopropylamine may increase the hypotensive activities of Amlodipine. Quinine may increase the hypotensive activities of Amlodipine. Dapoxetine may increase the orthostatic hypotensive activities of Valsartan. Rilmenidine may increase the hypotensive activities of Valsartan. The metabolism of Ketoprofen can be decreased when combined with Valsartan. The metabolism of Valsartan can be decreased when combined with Nicardipine. The risk or severity of adverse effects can be increased when Morphine is combined with Amlodipine. Debrisoquin may increase the hypotensive activities of Valsartan. Amlodipine may increase the hypotensive activities of Bupranolol. The metabolism of Amlodipine can be decreased when combined with Darunavir. The risk or severity of adverse effects can be increased when Rotigotine is combined with Amlodipine. The therapeutic efficacy of Amlodipine can be decreased when used in combination with Calcium Gluceptate. The metabolism of Amlodipine can be decreased when combined with Delavirdine. The risk or severity of adverse effects can be increased when Amlodipine is combined with Bisoprolol. The risk or severity of adverse effects can be increased when Valsartan is combined with Serrapeptase. The risk or severity of adverse effects can be increased when Hexetidine is combined with Amlodipine. Indoramin may increase the hypotensive activities of Amlodipine. The risk or severity of adverse effects can be increased when Amlodipine is combined with Fosinopril. The risk or severity of adverse effects can be increased when Amlodipine is combined with Magnesium Sulfate. The risk or severity of adverse effects can be increased when Valsartan is combined with Apremilast. The serum concentration of Amlodipine can be increased when it is combined with Ivacaftor. The metabolism of Enasidenib can be decreased when combined with Valsartan. The metabolism of Lesinurad can be decreased when combined with Valsartan. The risk or severity of adverse effects can be increased when Valsartan is combined with Dexmedetomidine. The risk or severity of adverse effects can be increased when Valsartan is combined with Nebivolol. Amlodipine may increase the hypotensive activities of Efonidipine. The metabolism of Valsartan can be decreased when combined with Amiodarone. Bethanidine may increase the hypotensive activities of Valsartan. The metabolism of Valsartan can be decreased when combined with Pyrimethamine. The risk or severity of adverse effects can be increased when Amlodipine is combined with Dexmedetomidine. The risk or severity of adverse effects can be increased when Amlodipine is combined with Benazepril. The risk or severity of adverse effects can be increased when Sodium Nitrite is combined with Amlodipine. The risk or severity of adverse effects can be increased when Ropivacaine is combined with Amlodipine. The risk or severity of adverse effects can be increased when Valsartan is combined with Chlorothiazide. The serum concentration of Rilpivirine can be increased when it is combined with Amlodipine.